Bharat Biotech's Covid nasal vaccine phase 3 trials completed
Published
The company will submit its data to the Drugs Controller General of India (DCGI) next month, said Dr Krishna Ella, Bharat Biotech chief.
Full ArticlePublished
The company will submit its data to the Drugs Controller General of India (DCGI) next month, said Dr Krishna Ella, Bharat Biotech chief.
Full Article"If everything is okay, then we will get permission to launch and it will be the world's first clinically proven nasal Covid-19..
In an exclusive interview with ANI, Dr Ella said, "We just completed a clinical trial, a data analysis is going on. Next month, we..